Compounds > sofosbuvir
Page last updated: 2024-08-25

sofosbuvir and carbon tetrachloride

sofosbuvir has been researched along with carbon tetrachloride in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
El-Sisi, AE; Zakaria, S1
Akhtar, MF; Anwar, F; Khan, A; Shah, SA; Yasmeen, S1

Other Studies

2 other study(ies) available for sofosbuvir and carbon tetrachloride

ArticleYear
Daclatasvir and Sofosbuvir Mitigate Hepatic Fibrosis Through Downregulation of TNF-α / NF-κB Signaling Pathway.
    Current molecular pharmacology, 2020, Volume: 13, Issue:4

    Topics: Animals; Carbamates; Carbon Tetrachloride; Disease Progression; Down-Regulation; Hepatic Stellate Cells; Imidazoles; Liver; Liver Cirrhosis; Male; NF-kappa B; Proto-Oncogene Proteins c-bcl-2; Pyrrolidines; Rats, Wistar; Sofosbuvir; Tumor Necrosis Factor-alpha; Valine

2020
An insight into the hepatoprotective role of Velpatasvir and Sofosbuvir per se and in combination against carbon tetrachloride-induced hepatic fibrosis in rats.
    Environmental science and pollution research international, 2023, Volume: 30, Issue:42

    Topics: Animals; Antioxidants; Antiviral Agents; Carbon Tetrachloride; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Interleukin-6; Liver Cirrhosis; NF-kappa B; Rats; Sofosbuvir

2023